Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors

被引:27
作者
Sandalon, Z [1 ]
Bruckheimer, EM [1 ]
Lustig, KH [1 ]
Rogers, LC [1 ]
Peluso, RW [1 ]
Burstein, H [1 ]
机构
[1] Targeted Genet Corp, Seattle, WA 98101 USA
关键词
D O I
10.1128/JVI.78.22.12355-12365.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study evaluated and compared delivery of the tumor necrosis factor alpha receptor (TNFR)-immunoglobulin G1 (IgG1) Fc fusion (TNFR:Fc) gene to the lung by single and repeat administrations of multiple pseudotyped adeno-associated virus (AAV) vectors as a means for achieving systemic distribution of the soluble TNFR:Fc protein. A single endotracheal administration of AAV[2/5]cytomegalovirus (CMV)-TNFR:Fc vector (containing the AAV2 inverted terminal repeats and AAV5 capsid) to the rat lung resulted in long-term, high levels of serum TNFR:Fc protein that gradually declined over a period of 8 months. Endotracheal delivery of AAV[2/1]CMV-TNFR:Fc resulted in serum TNFR:Fc protein levels that were detectable for at least 4 months but were 10-fold lower than that of the AAV [2/5] vector. In contrast, secretion of the TNFR:Fc protein following pulmonary delivery of AAV[2/2]CMV-TNFR:Fc vector was very inefficient, and the protein was detected in the blood only when an airway epithelial cell-specific promoter, CC10, was substituted for the CMV enhancer/promoter to control transgene expression. In the context of AAV[2/5], the CC10 promoter was as efficient as CMV enhancer/promoter in generating similar levels of systemic TNFR:Fc protein, suggesting that this protein is secreted primarily from the airway epithelium. In mice, comparable long-term secretion of TNFR:Fc protein was demonstrated after AAV[2/2] and AAV[2/5] delivery, although the kinetics of transduction appeared to be different. All pseudotyped AAV vectors elicited serum anti-AAV capsid-neutralizing antibody responses, but these did not prevent lung transduction and efficient secretion of TNFR:Fc protein to the circulation following readministration with AAV[2/5]. These results highlight the potential utility of AAV vectors containing serotype 5 capsid to deliver and redeliver genes of secreted proteins to the lung to achieve long-term systemic protein expression.
引用
收藏
页码:12355 / 12365
页数:11
相关论文
共 54 条
  • [31] IMMUNOGLOBULIN-G SUBCLASS PROTEINS IN SERUM AND LAVAGE FLUID OF NORMAL SUBJECTS - QUANTITATION AND COMPARISON WITH IMMUNOGLOBULIN-A AND IMMUNOGLOBULIN-E
    MERRILL, WW
    NAEGEL, GP
    OLCHOWSKI, JJ
    REYNOLDS, HY
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 131 (04): : 584 - 587
  • [32] Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector
    Mingozzi, F
    Schüttrumpf, J
    Arruda, VR
    Liu, YH
    Liu, YL
    High, KA
    Xiao, WD
    Herzog, RW
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (20) : 10497 - 10502
  • [33] Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial
    Moss, RB
    Rochman, D
    Spencer, LT
    Aitken, ML
    Zeitlhi, PL
    Waltz, D
    Milla, C
    Brody, AS
    Clancy, JP
    Ramsey, B
    Hamblett, N
    Heald, AE
    [J]. CHEST, 2004, 125 (02) : 509 - 521
  • [34] Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3
    Muramatsu, S
    Mizukami, H
    Young, NS
    Brown, KE
    [J]. VIROLOGY, 1996, 221 (01) : 208 - 217
  • [35] Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver
    Nakai, H
    Herzog, RW
    Hagstrom, JN
    Walter, J
    Kung, SH
    Yang, EY
    Tai, SJ
    Iwaki, Y
    Kurtzman, GJ
    Fisher, KJ
    Colosi, P
    Couto, LB
    High, KA
    [J]. BLOOD, 1998, 91 (12) : 4600 - 4607
  • [36] Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo
    Nakai, H
    Fuess, S
    Storm, TA
    Meuse, LA
    Kay, MA
    [J]. MOLECULAR THERAPY, 2003, 7 (01) : 112 - 121
  • [37] Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
    Qing, K
    Mah, C
    Hansen, J
    Zhou, SZ
    Dwarki, V
    Srivastava, A
    [J]. NATURE MEDICINE, 1999, 5 (01) : 71 - 77
  • [38] Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
    Rabinowitz, JE
    Rolling, F
    Li, CW
    Conrath, H
    Xiao, WD
    Xiao, X
    Samulski, RJ
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (02) : 791 - 801
  • [39] Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
    Rutledge, EA
    Halbert, CL
    Russell, DW
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (01) : 309 - 319
  • [40] Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
    Sarkar, R
    Tetreault, R
    Gao, GP
    Wang, LL
    Bell, P
    Chandler, R
    Wilson, JM
    Kazazian, HH
    [J]. BLOOD, 2004, 103 (04) : 1253 - 1260